Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on May 08, 2014 9:38am
204 Views
Post# 22537823

RE:RE:RE:RE:RE:RVX - EVENTS/WEBCASTS section updated...

RE:RE:RE:RE:RE:RVX - EVENTS/WEBCASTS section updated...Hi GV. Good perspectives.

After seeing various posts the single location change is probably a cost cutting move as you said.

Thinking crazily outside the box re the corporate structure side IF Zenith was folded back into RVX (RVX buys Zenith (a private company)) then there would be some boost to the RVX share price and in a combined way the Zenith shares gain liquidity that we currently don't have. 

Anyway, that's just hypothetical nonsense and of little value in terms of corporate benefit and the $6mm from KD and $2mm from NGN put into Zenith moving under the RVX umbrella would be an issue.

Let's just hope Don is well on his way to locking up the blockbuster deal. So many great assets here so I hope he can capitalize on them for the benefit of all (soon).

I'm not awake enough to provide a cogent perspective at this stage of the day.
Cheers
Toinv
Bullboard Posts